Advertisement

Topics

REPLICor Inc Company Profile

04:37 EST 15th December 2018 | BioPortfolio

REPLICor Inc. is a biopharmaceutical company developing novel broad-spectrum antiviral drugs. Its lead compound, REP 9, is active against 12 viral families including influenza, hepatitis B and C, HIV, RSV and herpes. The company’s business strategy is to enter into an alliance with a major pharmaceutical company to further develop and market its technology.

Location

500, Cartier Blvd WestSuite 135
Laval
Quebec
H7V 5B7
Canada

Contact

Phone: (450) 688-6068
Fax: (450) 688-3138
Email: info@replicor.com


News Articles [2 Associated News Articles listed on BioPortfolio]

Very interesting #HBV program this year at #AASLD18 $GILD : TLR8 agonist $SBPH : RIG-I agonist $ARWR : RNAi $RHHBY: TLR7 agonist, Core protein allosteric modulator $JNJ : capsid modulator $ASMB : core inhibitor $CTRV : TXL, cyclophilin ihnibitor #Replico

Very interesting #HBV program this year at #AASLD18 $GILD : TLR8 agonist $SBPH : RIG-I agonist $ARWR : RNAi $RHHBY: TLR

KOL Perspectives: Perceptions of recent upcoming data for key HBV pipeline agents [Report Updated: 02102018] Prices from USD $2125

KOL Perspectives: Perceptions of recent upcoming data for key HBV pipeline agentsSummaryThis KOL Insight briefing focuses on KOLs views of recent upcoming data for key HBV pipeline agents.Questions ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Replicor Inc.

Replicor is a privately held biopharmaceutical company with the most advanced animal and human clinical data in the development of the cure for HBV and HDV. The company is dedicat...

REPLICor Inc

REPLICor Inc. is a biopharmaceutical company developing novel broad-spectrum antiviral drugs. Its lead compound, REP 9, is active against 12 viral families including influenza, hepatitis B and C, HIV,...

REPLICor Incorporated

REPLICor is focused on discovering and developing a technology based upon the biological mechanisms of the initiation of DNA replication. Notwithstanding its focus, the company has access to a broadly...

More Information about "REPLICor Inc" on BioPortfolio

We have published hundreds of REPLICor Inc news stories on BioPortfolio along with dozens of REPLICor Inc Clinical Trials and PubMed Articles about REPLICor Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of REPLICor Inc Companies in our database. You can also find out about relevant REPLICor Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Swine Flu - H1N1 influenza - H7N9
Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010. It is also referred to as H1N1 influenza (because it is the H1N1 strain of virus). The H1N1 flu virus will be one of the main vi...


Corporate Database Quicklinks



Searches Linking to this Company Record